Based on the Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF stock forecast from 0 analysts, the average analyst target price for Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF is not available over the next 12 months. Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF is Bearish, which is based on 1 positive signals and 4 negative signals. At the last closing, Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF’s stock price was USD 39.62. Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF’s stock price has changed by +1.44% over the past week, +7.50% over the past month and +32.91% over the last year.
No recent analyst target price found for Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF
No recent average analyst rating found for Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF
The fund normally invests at least 80% of its net assets (including borrowings for investment purposes) in the equity securities that comprise the index. The index seeks to provide opportunistic investment exposure to those stocks with the potential to break out, or experience a period of sustained price growth beyond the stock"s recent "resistance level," with consideration for various market conditions. The fund is non-diversified. Read Less
The fund normally invests at least 80% of its net assets (including borrowings for investment purposes) in the equity securities that comprise the index. The index seeks to provide opportunistic investment exposure to those stocks with the potential to break out, or experience a ...Read More
Stock Target Advisor's fundamental analysis for Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF's stock is Bearish.
BOUT stock's dividend yield is 1.21%.
Our analysis grades BOUT stock's dividend yield at A-. This means that BOUT stock's dividend yield is above 92% of the stocks in the Mid-Cap Growth sector in the NYE exchange.
Based on this BOUT may be a good dividend stock for its sector.
Unfortunately we do not have enough data on BOUT's stock to indicate what its average analyst target is.
BOUT stock's Price/Earning ratio is 25.90.
Our analysis grades BOUT stock's Price / Earning ratio at F. This means that BOUT stock's Price/Earning ratio is above 75% of the stocks in the Mid-Cap Growth sector in the NYE exchange.
Based on this BOUT may be a overvalued for its sector.
The last closing price of BOUT's stock was USD 39.62.
The most recent market capitalization for BOUT is USD 0.01B.
Unfortunately we do not have enough analyst data on BOUT's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF's stock.
Sorry, we do not have any data on the number of employees for Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF.
Sorry we do not have any infomation available on Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
High dividend returns
The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Stock Target Advisor's fundamental analysis for Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF's stock is Bearish.
BOUT stock's dividend yield is 1.21%.
Our analysis grades BOUT stock's dividend yield at A-. This means that BOUT stock's dividend yield is above 92% of the stocks in the Mid-Cap Growth sector in the NYE exchange.
Based on this BOUT may be a good dividend stock for its sector.
Unfortunately we do not have enough data on BOUT's stock to indicate what its average analyst target is.
BOUT stock's Price/Earning ratio is 25.90.
Our analysis grades BOUT stock's Price / Earning ratio at F. This means that BOUT stock's Price/Earning ratio is above 75% of the stocks in the Mid-Cap Growth sector in the NYE exchange.
Based on this BOUT may be a overvalued for its sector.
The last closing price of BOUT's stock was USD 39.62.
The most recent market capitalization for BOUT is USD 0.01B.
Unfortunately we do not have enough analyst data on BOUT's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF's stock.
Sorry, we do not have any data on the number of employees for Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF.
Sorry we do not have any infomation available on Innovator ETFs Trust - Innovator IBD Breakout Opportunities ETF's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BOUT !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
